Paris-based medtech Metyos snaps €2.3 million to improve the lives of millions of chronic kidney disease patients

Published on March 26, 2024

Metyos, a medtech startup on a mission to relieve the burden of chronic kidney disease (CKD) on patients and healthcare systems worldwide, has raised €2.3 million in pre-seed funding. The funding was led by Cenitz with participation from KIMA Ventures, Advans Lab, and Bpifrance alongside doctors, leading health insurance angels, and business leaders from Implicity,…

This content is for members only. Visit the site and log in/register to read.

The post Paris-based medtech Metyos snaps €2.3 million to improve the lives of millions of chronic kidney disease patients appeared first on EU-Startups.